ShockWave Medical Inc. (SWAV)
NASDAQ: SWAV
· Real-Time Price · USD
334.75
-0.08 (-0.02%)
At close: May 30, 2024, 10:00 PM
ShockWave Medical Revenue Breakdown
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Coronary Revenue | 164.53M | 152.87M | 136.32M | 125.78M | 113.88M | 102.65M | 93.04M | 87.83M | 70.34M | 62.29M | 47.16M | 36.7M | 15.31M |
| Coronary Revenue Growth | +7.63% | +12.13% | +8.39% | +10.45% | +10.93% | +10.33% | +5.94% | +24.87% | +12.92% | +32.06% | +28.51% | +139.76% | n/a |
| Peripheral Revenue | 51.84M | 48.12M | 47.84M | 52.26M | 46.13M | 40.5M | 37.05M | 31.89M | 22.85M | 21.41M | 17.73M | 18.79M | 16.14M |
| Peripheral Revenue Growth | +7.74% | +0.59% | -8.47% | +13.29% | +13.90% | +9.33% | +16.18% | +39.53% | +6.76% | +20.76% | -5.68% | +16.43% | n/a |
| Product and Service, Other Revenue | 599K | n/a | 572K | 895K | 1.06M | n/a | 1.24M | 1.03M | 442K | n/a | n/a | n/a | n/a |
| Product and Service, Other Revenue Growth | n/a | n/a | -36.09% | -15.65% | n/a | n/a | +20.35% | +133.48% | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Other Countries Revenue | 17.01M | 21.88M | 19.77M | 16.31M | 13.21M | 11.93M | 9.07M | 7.26M | 3.04M | 3.28M | 3.76M | 2.58M | 2.63M | 3.32M | 1.67M | 817K | 1.41M | 1.03M | 786K | 658K | 254K |
| All Other Countries Revenue Growth | -22.25% | +10.68% | +21.22% | +23.47% | +10.71% | +31.60% | +24.94% | +138.29% | -7.25% | -12.69% | +46.02% | -2.20% | -20.62% | +98.74% | +104.28% | -42.02% | +36.80% | +31.04% | +19.45% | +159.06% | n/a |
| Europe Revenue | 26.26M | 23.01M | 19.35M | 18.91M | 16.23M | 13.79M | 11.76M | 13.39M | 12.07M | 11.3M | 8.62M | 10.42M | 21.05M | 12.67M | 11.14M | 5.54M | 7.77M | 7.64M | 6.25M | 5.17M | 3.64M |
| Europe Revenue Growth | +14.11% | +18.92% | +2.31% | +16.51% | +17.75% | +17.22% | -12.18% | +11.00% | +6.74% | +31.09% | -17.24% | -50.49% | +66.09% | +13.70% | +101.26% | -28.73% | +1.62% | +22.40% | +20.77% | +42.24% | n/a |
| United States Revenue | 175.53M | 158.09M | 146.9M | 144.94M | 131.62M | 118.31M | 110.5M | 100.1M | 78.52M | 69.59M | n/a | 42.91M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | +11.04% | +7.61% | +1.35% | +10.12% | +11.25% | +7.06% | +10.40% | +27.48% | +12.82% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 103.72M | 92.06M | 78.36M | 86.47M | 73.22M | 60.38M | 56.52M | 53.68M | 48.35M | 42.82M | 37.66M | 34.34M | 31.22M | 23.07M | 19.23M | 16.6M | 16.64M | 14.05M | 11.63M | 10.21M | 8.87M | 6.77M | 6.17M | 5.76M | 4.81M |
| Selling, General, and Administrative Revenue Growth | +12.67% | +17.49% | -9.38% | +18.10% | +21.26% | +6.83% | +5.28% | +11.02% | +12.91% | +13.71% | +9.67% | +10.00% | +35.34% | +19.96% | +15.81% | -0.19% | +18.42% | +20.79% | +13.94% | +15.04% | +31.11% | +9.68% | +7.04% | +19.73% | n/a |
| Research and Development Revenue | 44.47M | 42.32M | 39.53M | 36.83M | 26.97M | 23.72M | 20.18M | 20.76M | 17.02M | 14.72M | 13.73M | 11.81M | 10.28M | 9.04M | 7.89M | 8.1M | 11.89M | 10.07M | 8.37M | 6.93M | 7.48M | 6.12M | 5.53M | 5.53M | 5.52M |
| Research and Development Revenue Growth | +5.07% | +7.07% | +7.32% | +36.55% | +13.69% | +17.57% | -2.81% | +21.98% | +15.64% | +7.15% | +16.25% | +14.97% | +13.63% | +14.61% | -2.59% | -31.87% | +18.01% | +20.40% | +20.82% | -7.46% | +22.31% | +10.59% | +0.05% | +0.25% | n/a |
| Sales and Marketing Revenue | 74.49M | 67.18M | 56.91M | 56.74M | 54.01M | 43.44M | 42.08M | 40.52M | 35.96M | 33.19M | 28.39M | 25.71M | 23.99M | 16.44M | 13.62M | 11.21M | 10.41M | 9.6M | 8.19M | 6.96M | 5.87M | 4.92M | 4.8M | 4.37M | 3.44M |
| Sales and Marketing Revenue Growth | +10.88% | +18.05% | +0.30% | +5.05% | +24.34% | +3.22% | +3.87% | +12.66% | +8.35% | +16.90% | +10.42% | +7.17% | +45.97% | +20.68% | +21.53% | +7.64% | +8.48% | +17.15% | +17.68% | +18.57% | +19.21% | +2.58% | +9.81% | +27.17% | n/a |